- Home
- RGC vs CRVO Comparison
RGC vs CRVO Comparison
Compare RGC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- CRVO
- Stock Information
- Founded
- RGC 2014
- CRVO 2001
- Country
- RGC Hong Kong
- CRVO United States
- Employees
- RGC N/A
- CRVO N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RGC Health Care
- CRVO Health Care
- Exchange
- RGC Nasdaq
- CRVO Nasdaq
- Market Cap
- RGC 171.1M
- CRVO 160.4M
- IPO Year
- RGC 2021
- CRVO N/A
- Fundamental
- Price
- RGC $5.32
- CRVO $19.17
- Analyst Decision
- RGC
- CRVO Strong Buy
- Analyst Count
- RGC 0
- CRVO 4
- Target Price
- RGC N/A
- CRVO $58.25
- AVG Volume (30 Days)
- RGC 29.9K
- CRVO 79.5K
- Earning Date
- RGC 10-25-2024
- CRVO 11-11-2024
- Dividend Yield
- RGC N/A
- CRVO N/A
- EPS Growth
- RGC N/A
- CRVO N/A
- EPS
- RGC N/A
- CRVO N/A
- Revenue
- RGC N/A
- CRVO $9,653,281.00
- Revenue This Year
- RGC N/A
- CRVO $47.04
- Revenue Next Year
- RGC N/A
- CRVO N/A
- P/E Ratio
- RGC N/A
- CRVO N/A
- Revenue Growth
- RGC N/A
- CRVO 585.67
- 52 Week Low
- RGC $3.03
- CRVO $4.28
- 52 Week High
- RGC $32.44
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- RGC 38.69
- CRVO 55.34
- Support Level
- RGC $5.52
- CRVO $14.83
- Resistance Level
- RGC $6.57
- CRVO $17.43
- Average True Range (ATR)
- RGC 0.76
- CRVO 1.76
- MACD
- RGC -0.27
- CRVO 0.04
- Stochastic Oscillator
- RGC 0.00
- CRVO 73.22
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.